Evidence map›Paper›PMID 39654612›Full record

ReviewFrontiers in pharmacology2024

Therapeutic potential and mechanisms of stem cells in major depressive disorder: a comprehensive review.

Jiaqi Li, Yuqian Wang, Yucheng Zhang, Mengran Liu, Xinao Rong, Jinlan Jiang

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. The Therapeutic Potential of Stem Cells in Depression.International journal of molecular sciences · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiaqi Li *Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
Yuqian Wang *Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
Yucheng ZhangScientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
Mengran LiuScientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
Xinao RongScientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
Jinlan JiangScientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a common affective disorder characterized by persistent low mood, diminished interest or pleasure in normally enjoyable activities, disturbances in sleep patterns, and suicidal ideation. Conventional treatments often yield unsatisfactory results and are associated with several adverse effects. However, emerging literature has highlighted the potential of stem cell (SC) transplantation as a promising avenue for treating depression owing to its favorable anti-inflammatory and neurotrophic properties. This review summarizes the therapeutic effects and underlying mechanisms associated with SC transplantation in depression, offering a conceptual framework for the future application of SCs in the clinical treatment of depression.

Indexed as

depressionimmunomodulationmechanismsreviewstem cells

Identifiers

PMID39654612
PMCPMC11625547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.